Quantum Linguistics in Patient-Clinical Trial Relations for Improved Healthcare
Abstract
The healthcare industry is undergoing a fundamental revolution with the integration of Quantum Natural Language Processing techniques for matching patient-clinical trials. This research envisions a paradigm where patients and clinical trials collaborate, changing the way healthcare is supplied and medical research is conducted. Apart from this, the research focuses on engaging patients in clinical trials. Patient involvement refers to the process by which patients and their healthcare providers collaborate to make decisions regarding their health. Within the framework of clinical studies, this may entail participants providing input on study designs or monitoring their data through wearable technology and smartphone apps. Quantum NLP has the potential to enhance patient outcomes and advance medical knowledge more quickly by enabling more precise and effective clinical trials. By setting the framework for future applications of quantum NLP, this study expands the conversation on the connection between quantum computing and healthcare.
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- In silico toxicology protocols
- Automated in Silico Design of Homogeneous Catalysts
- In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications
- mRNA codon optimization with quantum computers
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.